Related Experiment Video
Updated: May 20, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials?
Joshua D Grill1, Sarah Monsell, Jason Karlawish
1Mary Easton Center for Alzheimer's Disease Research, Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA. jgrill@mednet.ucla.edu
Background/Aims:
Alzheimer's disease (AD) clinical trials enroll two participants: a patient and a study partner. The primary caregiver most often fills the role of study partner and most trial study partners are spousal caregivers.
Methods:
AD trial inclusion criteria were applied to baseline data from 5,674 probable AD dementia research participants in the National Alzheimer's Coordinating Center Uniform Data Set. Eligibility was compared among patients with spousal, adult child, and other types of study partners.
Results:
Patients with spousal study partners were more frequently eligible than patients with adult child study partners. Compared to patients with spousal study partners, patients with adult child study partners were more frequently ineligible because of age, residence in skilled nursing facility, low scores on the Mini-Mental State Examination, highscores on the Hachinski Ischemia Scale, and failure to fulfill a minimum number of weekly visits with the study partner.
Conclusions:
In this sample, patients with adult child study partners were less likely to qualify for AD clinical trials than were patients with spousal study partners. This may contribute to the lower representation of patients with adult child caregivers in these studies.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Alzheimer's Disease: Treatment
Case Studies
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blind Procedures
